Guardian Investor Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$740K Hold
11,476
0.59% 39
2014
Q4
$677K Sell
11,476
-284
-2% -$16K 0.54% 40
2014
Q3
$602K Sell
11,760
-469
-4% -$23.4K 0.48% 45
2014
Q2
$593K Sell
12,229
-468
-4% -$23.1K 0.46% 49
2014
Q1
$660K Sell
12,697
-496
-4% -$26.4K 0.51% 43
2013
Q4
$701K Buy
13,193
+33
+0.3% +$1.68K 0.53% 39
2013
Q3
$609K Sell
13,160
-141
-1% -$6.19K 0.51% 39
2013
Q2
$594K Buy
+13,301
New +$577K 0.51% 38

Other funds holding BMY

Guardian Investor Services's BMY Position: Q1 2015 in Review

Guardian Investor Services held its Bristol-Myers Squibb (BMY) position steady in Q1 2015 at 11,476 shares worth $740K. The position accounts for 0.59% of the portfolio, ranked #39.

Guardian Investor Services first reported a position in BMY in Q2 2013 and has held it in 8 quarters since. 1,450 funds tracked by Wall St. Rank hold BMY as of Q1 2015.

  • Guardian Investor Services held 11,476 shares of Bristol-Myers Squibb worth $740K as of Q1 2015.
  • Guardian Investor Services left its Bristol-Myers Squibb share count unchanged in Q1 2015.
  • Bristol-Myers Squibb made up 0.59% of Guardian Investor Services's portfolio in Q1 2015, its #39 holding.
  • Guardian Investor Services first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 8 quarters since.
  • 1,450 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2015.

Based on Guardian Investor Services's 13F filing for Q1 2015, filed 5 May 2015.